http://orcid.org/0000-0002-1916-6348
Figures
Abstract
Introduction
Studies report that intense physical activity influences the down-regulation of immune function in athletes as well as the interaction between adipose tissue and the immune system.
Aim
This study aimed to compare the plasma soluble levels of the immune checkpoint HLA-G (sHLA-G) molecule with the fat mass and muscle mass index among 77 bodybuilders and 64 controls.
Results
The comparisons of the percentage of body fat (%BF) revealed that the groups of male and female bodybuilders showed a statistically significant reduction in the percentage of body fat when compared to their control group, (P <0.0001, for both comparisons). Regarding sHLA-G levels, the comparisons showed that the group of male bodybuilders had significantly higher sHLA-G levels compared to the group of female bodybuilders (P = 0.0011).
Conclusion
Our results showed that in bodybuilders with less body fat, the systemic levels of soluble HLA-G, an immunological molecule with recognized immunosuppressive function, are significantly higher and suggest that this immune mechanism may corroborate the immunosuppressive state in athletes undergoing intense and prolonged physical training.
Citation: Fernandes TM, Puggina EF, Mendes-Junior CT, de Paula MC, Sonon P, Donadi EA, et al. (2020) High plasma soluble levels of the immune checkpoint HLA-G molecule among bodybuilders. PLoS ONE 15(9): e0238044. https://doi.org/10.1371/journal.pone.0238044
Editor: Mauro Lombardo, San Raffaele Roma Open University, ITALY
Received: April 28, 2020; Accepted: August 7, 2020; Published: September 30, 2020
Copyright: © 2020 Fernandes et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the manuscript and its Supporting Information files.
Funding: The author(s) received no specific funding for this work.
Competing interests: The authors have declared that no competing interests exist.
Introduction
In contrast to moderate or intermittent physical activity, prolonged and intensive exertion causes numerous changes in immunity that possibly reflects on immunological suppression. In fact, evidence indicates that intense physical activity may downregulate the immune function and increase the risk of certain types of infection [1, 2]. Indeed, bodybuilding athletes are submitted to high intensity resistance training to develop muscular hypertrophy (size), to reduce the amount of subcutaneous fat, and to slow down the rate of recovery from fatigue after exercise [3–5].
Exercise-induced immune depression has a multifactorial origin, depending on mechanisms related to neuro/immune/endocrine systems. Evidence shows that prolonged periods of intense training may alter the profile of immune cells, including lymphopenia [6, 7] mucosal immunoglobulin levels [3], impaired phagocytosis [8, 9], and natural killer cell cytotoxicity (NKCA) [10].
Human leukocyte antigens (HLA) are involved in several important functions of the immune system, starting from antigen presentation to lymphocytes, performed by the classical class I histocompatibility molecules (HLA-A/B/C), and extending until the control of the immune response, as performed by the non-classical class I molecules (HLA-E/F/G). Among these molecules, HLA-G is the most studied one, and its major function is the down-regulation of the activity of the innate and adaptive immune system cells, by means of the interaction with ILT-2/4 inhibitory leukocyte receptors. Accordingly, HLA-G may inhibit the proliferation of T and B lymphocytes [11, 12], the activity of antigen-presenting cells (APC) [13] and the cytotoxicity of TCD8 and Natural Killer (NK) cells [11]. Because of these properties, HLA-G has been recognized as an immune check point molecule. In certain infections and in some types of cancer, the overexpression of HLA-G can create a tolerogenic environment; inhibiting several steps of the immune response, propitiating the spreading of infectious and malignant cells [14]. In contrast, in transplanted organs and autoimmune disorders the expression of HLA-G may produce beneficial effects.
Considering that: i) numerous studies report that intense physical activity may down-regulate the immune function in athletes [5, 8–10], ii) the reported interactions between adipose tissue and the immune system [15] may be affected by the low amount of subcutaneous fat in bodybuilders [3, 4], and iii) HLA-G down-regulates the function of cells of the innate and adaptive immune system [11–14], this study aimed to evaluate the soluble HLA-G levels among bodybuilders, stratified according to fat mass and muscle mass index.
Materials and methods
Sample
The sample consisted of 141 healthy individuals categorized into 77 bodybuilders and 64 controls, who presented no infections, immunological or metabolic disorders at the time of inclusion in the study. The bodybuilder group was composed of 50 (65%) male bodybuilders (MB) with a mean age of 33.6 years and 27 (35%) female bodybuilders (FB) with a mean age of 33.2 years. The control group was composed of 24 (37.5%) female controls (FC) with a mean age of 28.0 years and 40 (62.5%) male controls (MC) with a mean age of 23.5 years. Due to lack of data for all individuals, analyses related to height, total body weight, lean, fat and body mass indexes were performed only with 14 females and 31 males in the control and 19 females and 33 males in the bodybuilders. The group of high performance bodybuilders was selected from the participants of the 48th Brazilian Championship of Bodybuilding and Fitness–IFBB 2018, held in the city of Ribeirão Preto, SP, Brazil. The athletes were assessed before or after the standard weighing process to championship. All bodybuilders reported following the American College of Sports Medicine (ACSM) recommendations for training with respect to hypertrophy. Bodybuilders preparing for competition followed self- or coach- prescribed diets, with the sole aim of supplying specific amounts of protein, fat and carbohydrate. The control group was selected from bodybuilders with at least 1 year of practicing the sport. This investigation was approved by the Ethics in Research Committee of the University of São Paulo at Ribeirão Preto School of Physical Education and Sport of Ribeirão Preto (EEFERP-USP, process#2,808,296). The athletes agreed to take part in this investigation by signing an informed consent form.
Anthropometry
Measurements were taken according to the International Society for the Advancement of Kineanthropometry guidelines (ISAK) [16], and from each subject the following variables were taken: i) anthropometric assessment for the determination of body composition (% of fat, lean mass, fat mass and BMI—Body Mass Index), ii) total weight, total stature, nine skinfolds (tricipital, subscapular, bicipital, chest, medium axillary, suprailiac, abdominal, front thigh, and medium calf), two muscle girths (flexed biceps, calf standing), and three bone breadths (elbow, ankle and knee).
The following evaluations were taken: i) weight was measured using the Welmy® (Santa Barbara D´Oeste, BRA) scale, with accuracy of 100 g; ii) height with a vertical metric scale with a 1 mm accuracy; iii) skinfold thickness was assess by a adipometer Cescorf® with a 0.2 mm accuracy; and iv) muscle girths were measured with a measuring tape Sanny Medical (Guangdong, China) with a 1 mm accuracy scale. After obtaining these values, we used the following equation to estimate body density of male athletes: DC (g/cm2) = 1,112–0.00043499 (∑7doc) + 0.00000055 (∑7doc)2- 0.00028826 (age); and, for women: DC (g/cm2) = 1.0970 - [0.00046971 (ST) + 0.00000056 (ST)2]—[0.00012828 (age)], developed by Jackson and Pollock, 1978 [17], followed by converting the result into a percentage of fat by applying the Siri Equation (1961):% G = [(4.95/D) - 4.50] x 100 [18].
Soluble HLA-G quantification
Soluble HLA-G (sHLA-G) was quantified using MEM-G/9 antibody, which recognizes the most abundant soluble isoforms (shed sHLA-G1 and secreted HLA-G5), and an anti-human β2-microglobulin antibody, respectively, as capture and detection antibodies [19]. Microtitration plates were coated with 10 μg/mL MEM-G/9 mouse-anti-human HLA-G mAb (Exbio, Praha, Czech Republic) and incubated overnight at 4°C. Plates were saturated with 300 μL ready to use diluent buffer (DAKO, Carpinteria, CA, USA) for 2 h. Plasma samples were diluted (½) in diluent buffer, tested in duplicate and incubated for 2 h. After incubation and washing, monoclonal anti-human beta2-microglobulin antibody (DAKO, Glostrup, Denmark), which recognizes the immobilized antibody sHLA-G complex, was added to the wells and incubated for 1 h. The plates were then incubated for 1 h with 100 μL (1:200) envision buffer + system HRP (DAKO, Carpinteria, CA, USA) to obtain anti-β2-microglobulin-horseradish peroxidase complex to improve the efficiency of the reaction. All incubation steps were performed at room temperature and followed by four washes using washing buffer (H2O, PBS 1X, 0.1% Tween 20). The plates were incubated for 30 min with substrate (Tetramethylbenzidine super sensitive-TMB, Sigma Aldrich, Saint Louis, MO, USA) and absorbance was measured at 450 nm after adding HCL (1 N). Total sHLA-G levels were determined from a five-point standard calibration curve using dilutions (12.5–200 ng/mL) of HLA-G5 purified from M8-HLA-G5 cell line culture supernatants. Results are presented in ng/mL.
Statistical analysis
Categorical variables were described using proportions and 95% confidence interval, and the continuous variables were described by the mean, median, amplitude and correlation. Continuous variables were compared by means of Student T test, Wilcoxon-Mann-Whitney rank-sum test and analysis of variance (ANOVA). We checked for normality of distribution using Kolmogorov-Smirnov normality test. Since deviations from normality were found, non-parametric tests were used, Kruskal-Wallis and Mann-Whitney tests. In all analyzes performed, two-tailed versions of the tests were used and a significance level of 5% (alpha = 0.05) was adopted. Such analyzes were performed using the program GraphPad InStat version 3.06, GraphPad Software (www.graphpad.com). For intergroup analyzes, Spearman's correlation was used, an analysis used to discover the relationship between the two variables that do not have a normal joint distribution.
Results
Anthropometric assessment
Total body mass (body weight) and height were evaluated, and the body weight for the MB group ranged from 67–108 kg (84.97 ± 10.45), for the FB group it ranged from 45.5–77 kg (58.45 ± 9.56), for MC it ranged from 59–98 kg (79.17 ± 11.64) and FC of 48–74 kg (642.42 ± 8.80). The height of individuals in the MB group ranged from 160–186 cm (175.63 ± 6.29), for the FB group from 153–176 cm (164.68 ± 6.94), for MC it ranged from 164–192 cm (176.10 ± 6.80) and FC of 153–170 cm (162.18 ± 6.151) (Table 1).
Comparisons of the Body Mass Index (BMI) between the different groups showed that the group of Male Bodybuilders has a significantly higher BMI compared to the Male Control (P = 0.0213) and Female Bodybuilders group (P <0.0001) (Table 1).
Percentage of Body Fat (%BF)
Comparisons of the percentage of body fat (%BF) between the groups revealed that the groups of male and female bodybuilders showed a statistically significant reduction in the percentage of body fat when compared to their control group, male (P <0.0001) and female (P <0.0001), respectively. The comparison between the groups of male and female bodybuilders showed that the group of male bodybuilders showed a significantly greater reduction in the percentage of body fat compared to the group of female bodybuilders (P <0.0001) (Table 1).
Lean Mass Index (LMI)
To enhance fitness in bodybuilders, LMI must have high levels associated with low levels of fat mass index. The LMI was calculated using the formula LMI = TBM-FMI, where: LMI = Lean Mass Index, TBM = Total Body Mass, FMI = Fat Mass Index. Table 1 shows the medians and comparisons between the different groups studied.
Comparisons of the LMI between the groups showed that the groups of male and female bodybuilders have significantly higher LMI compared to the male (P<0.0001) and female (P = 0.0062) control groups, respectively. The control groups and male bodybuilders had significantly higher LMI compared to the control (P<0.0001) and female bodybuilder (P<0.0001) groups, respectively.
Fat Mass Index (FMI)
For the calculation of fat mass, the formula FMI = TBM x %BF/100 was used, where: FMI = Fat Mass Index, TBM = Total Body Mass, %BF = Body Fat Percentage. Table 1 shows the medians and comparisons between the different groups studied.
Comparisons of the FMI between the groups showed that male and female bodybuilders have significantly lower FMI compared to the male (P <0.0001) and female (P <0.0001) control groups, respectively. Among the controls, the male control group had significantly lower FMI compared to the female control group (P = 0.0485).
Plasma levels of soluble HLA-G
Plasma levels of soluble HLA-G were analyzed and for the FM group their levels ranged from 0–932.14 ng/mL (109.29 ± 135.29), for the FF group from 8.89–330 ng/mL (67.27 ± 31.3), for CM of 4.58–604.58 ng/mL (88.75 ± 105.37) and CF of 0–355.45 ng/mL (60 ± 87.6) (Fig 1).
sHLA-G levels among MB were significantly higher when compared to FB. The horizontal bars in bold represent the medians.
Comparisons of plasma levels of soluble HLA-G (sHLA-G) showed that the group of male bodybuilders had significantly higher levels of sHLA-G compared to the group of female bodybuilders (P = 0.0011) (Table 1).
Considering that the age difference between the groups MB (33.6 years) and MC (23.5 years) was of almost 10 years, we also correlated results according to age and gender in the four studied groups. According to age, the following correlations were performed: i) (MB: rho = 0.0233; P = 0.8724; ii) FB: rho = -0.0724; P = 0.7196; iii) MC: rho = -0.0330; P = 0.8400; and FC: rho = 0.2936; P = 0.1638). According to gender, the following correlations were evaluated: i) (males: rho = 0.1032; P = 0.3330; females: rho = 0.1708; P = 0.2307) or in the entire sample (rho = 0.0872; P = 0.3037). These analyses revealed that age and gender did not influence intragroup results.
When compared to the different groups, male bodybuilders (MB) had significantly higher values of sHLA-G and significantly lower values of Fat Mass Index (FMI) and Percentage of Body Fat (%BF), we explored intra-group comparisons (Table 1).
Intragroup correlations (Table 2) showed that MB individuals with lower %BF had significantly higher levels of sHLA-G (P = 0.0073). Similarly, individuals with lower FMI had significantly higher levels of sHLA-G (P = 0.0087).
Discussion
The immune system presents several mechanisms for regulating the inflammatory response. Several immunological mediators have anti-inflammatory and immunoinhibitory functions, among these, HLA-G presents a well-recognized immunomodulatory activity [17–20]. This is the first study to assess plasmas HLA-G levels in bodybuilders, highlighting male to female and intragroup differences. In short, sHLA-G levels were augmented in: i) male bodybuilders (MB) compared to female bodybuilders (FB) (P = 0.0011), ii) the correlation between MB evidenced an inverse relationship between body fat and sHLA-G levels.
Studies have shown that adipose tissue secretes various inflammation-related cytokines, such as leptin and IL—6, which can induce chronic low-grade inflammation in obese individuals, with a concomitant stimulation of sHLA-G production, which has anti-inflammatory activities [21, 22]. This mechanism is possibly due to compensate the chronic pro-inflammatory state of obesity. Other studies indicate that the presence of higher levels of sHLA-G in patients with chronic diseases could, provisionally, represent a way to compensate the inflammatory condition [23].
Studies that measured the chronic effects of moderate or intermittent physical exercise point to local and systemic reduction of pro-inflammatory mediators, with attenuation in the production and secretion of acute phase proteins [24], and greater production and secretion of cytokines with anti-inflammatory function (especially IL-6 in skeletal muscle tissue and blood) [25]. The literature also suggests that the beneficial effects of physical training on the modulation of inflammation depend on the quality and quantity of stimuli, which are directly related to the rest time between stimuli to avoid the emergence of the stress condition [26]. In this context, it is also reported that physical exercise when intensively performed contributed to increase the incidence of upper respiratory tract infection, while exercise of moderate intensity would have a protective effect against the risk of infections [27, 28].
Considering the relationship between susceptibility to infections and inflammatory\immunologicalmediators associated with the practice of physical exercise, we sought to understand what possible mechanisms may modulate the immune response, primarily focusing on HLA-G. According to Costa Rosa and Vaisberge, 2002 [26], cellular and humoral components are mobilized from the immune system in response to mechanical (hypoxia, hyperthermia and muscle damage), metabolic (glutamine) and hormonal (adrenaline, cortisol) changes imposed by exercise [27].
In normal muscle, HLA-G is undetectable. However, in the context of inflammation, muscle fibers express HLA-G in a distribution similar to classical HLA class I molecules, as well as under stimulation of inflammatory cytokines, such as IFN-gamma [29]. In inflammatory myopathy, CD8 T cells destroy non-necrotic muscle fibers, showing a response mediated by HLA class I restricted cytotoxic T cells against surface antigens expressed in muscle fibers. Marzuillo et al. [30] reported that muscle fibers, in an inflamed environment, co-express HLA-G, raising the intriguing possibility that HLA-G protects muscle fibers from injury mediated by NK cells [31, 32]. Locally accumulated inflammatory cells produce a multitude of pro-inflammatory cytokines, including TNF-alpha and IFN-gamma. As these cytokines are known to induce HLA expression in many cell types, it seems likely that HLA-G expression, seen in inflammatory myopathies, at least in part, results from stimulation by locally produced cytokines after injury [33].
Insufficient physical exercise is related to the development of several diseases and metabolic changes, such as decreased insulin sensitivity, changes in lipid metabolism, increased visceral adiposity, decreased lean body mass and loss of muscle strength, resulting in low-grade chronic inflammation [34]. On the other hand, muscle damage, resulting from physical exercise, may initially result in a condition of acute inflammation with an increase in the production of myocins and activation of immune system cells to the site of muscle damage in order to initiate the tissue remodeling and repair process [35]. Noteworthy, it has been shown that systematic physical training can lead to a local and systemic anti-inflammatory state that enables tissue regeneration and adaptation and, at the same time, protects the organism against the development of chronic inflammatory pathologies [36]. In other words, an increase in the pro-inflammatory organic condition, caused by the stimulation of acute exercise, would be counterbalanced by the chronic anti-inflammatory environment, caused by systematic exercise, which would restrict the magnitude and duration of the inflammation. Thus, the beneficial effects of physical training on the modulation of inflammation depend on the quality and quantity of stimuli, which are directly related to the rest time between stimuli [37]. Thus, transversal and longitudinal data suggest that people who perform regular exercises of moderate intensity maintain a protective state [28, 38]. However, intense and prolonged exercise has been associated with greater morbidity and mortality [4, 39]. These findings gave rise to the "J"-shaped model, related the relationship between the exercise dose and the risk of infection. This model reports that moderate exercise may lower the risk of upper respiratory infection, whereas excessive exercise may increase the risk. Indeed, greater risk for upper respiratory infection is observed in over-trained compared with well-trained athletes [40].
Finally, our results present important evidence related to the immunological profile in bodybuilders, associating the decreased body fat to an increased plasma sHLA-G levels, indicating that, at least in part, HLA-G may contribute to the immunosuppressive state of athletes undergoing intense and prolonged physical training. Indeed, bodybuilding performed with extreme training to optimize lean mass and reduce the rate of body fat [31] may be associated with immunosuppression process [41], which has been attributed to exhaustive and prolonged exercises [32, 42, 43]. This cross-sectional study presents data obtained only at the time of championship, and long-term follow-up studies evaluating the role of diet, supplements and the role of the innate and adaptive immune response are needed to clarify the influence of intense physical exercise on the immune function.
References
- 1. Stewart LK, Flynn MG, Campbell WW, et al. The influence of exercise training on inflammatory cytokines and C-reactive protein. Med Sci Sports Exerc. 39:1714–1719, 2007. pmid:17909397
- 2. Uchida MC, Nosaka K, Ugrinowitsch C, et al. Effect of bench press exercise intensity on muscle soreness and inflammatory mediators. J Sports Sci. 27: 499–507, 2009. pmid:19253084
- 3. Nieman DC, Nehlsen-Cannarella SL. The effects of acute and chronic exercise of immunoglobulins. Sports Med. 11:183–201, 1991. pmid:2047622
- 4. Ekblom B, Ekblom O, Malm C. Infectious episodes before and after a marathon race. Scandinavian Journal of Medicine and Science in Sports 16(4):287–293, 2006. pmid:16895535
- 5. Huygens W, Claessens AL, Thomis M, et al. Body composition estimations by BIA versus anthropometric equations in body builders and other power athletes. J Sports Med Phys Fitness 42: 45–55, 2002. pmid:11832874
- 6. Jürimäe J, Purge P, Jürimäe T. Adiponectin and stress hormone responses to maximal sculling after volume-extended training season in elite rowers. Metabolism 55:13–19, 2006. pmid:16324914
- 7. Kleiner SM, Bazzarre TL, Ainsworth BE. Nutritional status of nationally ranked elite bodybuilders. Int J Sport Nutr. 4:54–69, 1994. pmid:8167655
- 8. Kleiner SM, Bazzarre TL, Litchford MD. Metabolic profiles, diet, and health practices of championship male and female bodybuilders. J Am Diet Assoc90:962–967, 1990. pmid:2365938
- 9. Kokkinos PF, Hurley BF, Vaccaro P, et al. Effects of low- and high-repetition resistive training on lipoprotein-lipid profiles. Med Sci Sports Exerc 20:50–54,1988.
- 10. Kraemer WJ, Ratamess NA. Hormonal responses and adaptations to resistance exercise and training. Sports Med35:339–361, 2005. pmid:15831061
- 11. Rouas-Freiss N, Goncalves RM, Menier C, Dausset J, Carosella ED. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci U S A94(21):11520–11525, 1997. pmid:9326642
- 12. Naji A, Menier C, Morandi F, et al. Binding of HLA-G to ITIM-bearing Ig-like transcript 2 receptor suppresses B cell responses. J Immunol 192(4): 1536–1546, 2014. pmid:24453251
- 13. Horuzsko A, Lenfant F, Munn DH, Mellor AL. Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice. Int Immunol13(3): 385–394, 2001. pmid:11222508
- 14. Fagerberg P. Negative Consequences of Low Energy Availability in Natural Male Bodybuilding: A Review. Int J Sport NutrExercMetab 28(4): 385–402, 2018.
- 15. Maurizi G, Della Guardia L, Maurizi A, Poloni A. Adipocytes properties and crosstalk with immune system in obesity-related inflammation. J Cell Physiol 233(1): 88–97, 2018. pmid:28181253
- 16.
ISAK. (2001). International Standards for Anthropometric Assessment. Under dale, S.A., ISAK.
- 17. Jackson AS, Pollock ML. Generalized equations for predicting body density of men. Br J Nutr 40: 497–504, 1978. pmid:718832
- 18.
GUEDES D.P. Composição corporal: princípios, técnicas e aplicações. 2ª edição. Londrina: APEF. 1994.
- 19. Rebmann V, Lemaoult J, Rouas-Freiss N, Carosella ED, Grosse-Wilde H. Report of the wet workshop for quantification of soluble HLA-G in Essen. Hum. Immunol 66: 853–863, 2005. pmid:16216668
- 20. González A, Rebmann V, LeMaoult J, et al. The immunosuppressive molecule HLA-G and its clinical implications. Critical Reviews in Clinical Laboratory Sciences, 49: 63–84, 2012. pmid:22537084
- 21. Gonen-Gross T, Achdout H, Gazit R, et al. Complexes of HLA-G protein on the cell surface are important for leukocyte Ig-like receptor-1 function. The Journal of Immunology 171(3): 1343–1351, 2003. pmid:12874224
- 22. Zidi I, Yahia HB, Bortolotti D, et al. Association between sHLA-G and HLA-G 14-bp deletion/insertion polymorphism in Crohn’s disease. International Immunology 27(6): 289–296, 2015. pmid:25577194
- 23. Kasapis C, Thompson PD. The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. Journal of the American College of Cardiology45(10): 1563–1569, 2005. pmid:15893167
- 24. Kim JI, Ho IC, Grusby MJ, Glimcher LH. The transcription factor c-Maf controls the production of interleukin-4 but not other Th2 cytokines. Immunity, 10(6): 745–751, 1999. pmid:10403649
- 25. Smith DA, Nicholls S, Morgan BA, Brown AJ, Quinn J. A conserved stress-activated protein kinase regulates a core stress response in the human pathogen Candida albicans. Molecular biology of the cell 15(9): 4179–4190, 2004. pmid:15229284
- 26. Rosa C, Bicudo LFP, Vaisberg MW. Influências do exercício na resposta imune. Revista brasileira de Medicina do Esporte 8(4): 167–172, 2002.
- 27. Calder PC, Dimitriadis G, Newsholme P. Glucose metabolism in lymphoid and inflammatory cells and tissues. Current Opinion in Clinical Nutrition & Metabolic Care 10(4): 531–540, 2007.
- 28. Nieman GW, Weertman JR, Siegel RW. Micro-hardness of nanocrystalline palladium and copper produced by inert-gas condensation. Scripta metallurgica 23(12): 2013–2018, 1989.
- 29. Yang Y, Chu W, Geraghty DE, Hunt JS. Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-gamma. The Journal of Immunology 156(11):4224–4231, 1996. pmid:8666791
- 30. Marzuillo P, Bellini G, Punzo F, et al. Association between 14 bp insertion/deletion HLA‐G functional polymorphism and insulin resistance in a cohort of Italian children with obesity. Pediatric diabetes 19(8): 1357–1361, 2018. pmid:30203576
- 31. Braud VM, Allan DS, McMichael AJ. Functions of nonclassical MHC and non-MHC-encoded class I molecules. Current opinion in immunology 11(1): 100–108, 1999. pmid:10047540
- 32. Le Bouteiller P, Blaschitz A. The functionality of HLA‐G is emerging. Immunological reviews 167(1): 233–244, 1999.
- 33. Petersen EW, Carey AL, Sacchetti M, et al. Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro: evidence that IL-6 acts independently of lipolytic hormones. Am. J. Physiol. Endocrinol. Metab288: 155–162, 2005.
- 34. Pedersen BK. The diseasome of physical inactivity–and the role of myokines in muscle–fat cross talk. The Journal of physiology 587(23): 5559–5568, 2009.
- 35. Tidball JG, Villalta SA. Regulatory interactions between muscle and the immune system during muscle regeneration. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 298(5): 1173–1187, 2010.
- 36. Pedersen BK, Febbraio MA. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nature Reviews Endocrinology 8(8): 457–465, 2012. pmid:22473333
- 37. Silva FOCD, Macedo D.V. Exercício físico, processo inflamatório e adaptação: uma visão geral. Revista Brasileira de Cineantropometria & Desempenho Humano 13(4): 320–328, 2011.
- 38. Wong PC, Chia M, Tsou IY, et al. Effects of a 12-week exercise training programme on aerobic fitness, body composition, blood lipids and C-reactive protein in adolescents with obesity. Ann Acad Med Singapore 37(4): 286–93, 2008. pmid:18461212
- 39. Heath GW, Macera CA, Nieman DC. Exercise and upper respiratory tract infections. Sports Medicine 14(6): 353–365, 1992. pmid:1470789
- 40. Nielsen HG. Exercise and Immunity. In: Hamlin M, Draper N and Kathiravel Yeditors. Current Issues in Sports and Exercise Medicine; 2013. pp.121–140. 2013.
- 41. Gleeson M. Immune function in sport and exercise. Journal of applied physiology 103(2): 693–699, 2007. pmid:17303714
- 42. Pedersen BK, Ostrowski K, Rohde T, Bruunsgaard H. The cytokine response to strenuous exercise. Canadian journal of physiology and pharmacology 76(5): 505–511, 1998. pmid:9839076
- 43. Rowbottom DG, Green KJ. Acute exercise effects on the immune system. Medicine & Science in Sports & Exercise 32(7): 396–405, 2000.